JBT Marel Crecimiento futuro
Future controles de criterios 3/6
Se prevé un crecimiento anual de los beneficios y los ingresos de JBT Marel de 41.4% y 4.9% respectivamente, mientras que el BPA crecerá en un 40.4% al año.
Información clave
41.4%
Tasa de crecimiento de los beneficios
40.42%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Machinery | 16.5% |
| Tasa de crecimiento de los ingresos | 4.9% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Good |
| Última actualización | 09 Sep 2026 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Actualización de narrativa • Aug 25
JBTM: Integration Self Help And Recurring Revenue Will Drive Future Upside
Analysts have fine tuned their view on JBT Marel, trimming the price target from $178.75 to $172.64 as they weigh updated assumptions on profitability and valuation against ongoing integration opportunities and execution risks highlighted in recent research. Analyst Commentary Recent research on JBT Marel highlights a mix of optimism around the integration story and caution around the execution needed to support the current valuation.Seeking Alpha • Aug 18
JBT Marel: Mr. Market Is Overreacting
Summary JBT Marel Corporation (JBTM) remains a soft ‘buy’ despite recent underperformance and a 10.1% stock decline versus the S&P 500. Revenue and profits are rising, with Q2 revenue at $981 million and net income up to $28 million, supporting a positive long-term outlook. Management reaffirmed revenue guidance but lowered adjusted EPS guidance to $7.85–$8.35; EBITDA guidance remains unchanged. Synergy realization, leverage reduction, and EBITDA margin expansion to 20% by 2028 could drive 12.5–14.7% annual upside if targets are met. Read the full article on Seeking AlphaArtículo de análisis • Aug 06
Earnings Miss: JBT Marel Corporation Missed EPS By 51% And Analysts Are Revising Their Forecasts
It's been a mediocre week for JBT Marel Corporation ( NYSE:JBTM ) shareholders, with the stock dropping 14% to US$122...Actualización de narrativa • Jun 16
JBTM: Recurring Revenue And Protein Leadership Will Drive Future Upside Potential
The JBT Marel analyst price target has been revised lower to $178.75 from $182.08, reflecting analysts' use of a reduced comparable group multiple, even as they highlight the company's positioning in food and protein processing and its mix of recurring, higher margin revenues. Analyst Commentary Recent research on JBT Marel highlights both optimism around the company’s position in food and protein processing and some caution around the assumptions that feed into valuation targets.
Actualización de narrativa • Jun 02
JBTM: Food Processing Execution Risk Will Limit Share Repurchase Upside
Analysts have trimmed their average price target on JBT Marel to $165 from $190, reflecting a lower comparable group multiple, even as they highlight the company’s growing role in food processing and its mix of secular growth, high margin recurring revenues, and strong free cash flow generation. Analyst Commentary Recent research highlights a split view on JBT Marel.Actualización de narrativa • May 18
JBTM: 2026 Sector Assumptions And Execution Will Shape Balanced Return Potential
Analysts have raised JBT Marel's price targets to $190 and $202 in recent updates, citing expected sector trends in 2026, changes in valuation, and refreshed models following the Q4 results as key reasons for the higher targets. Analyst Commentary Recent research updates on JBT Marel highlight higher price targets of $190 and $202, tied to refreshed models after Q4 results, sector expectations for 2026, and reassessments of valuation.Artículo de análisis • May 14
Solid Earnings Reflect JBT Marel's (NYSE:JBTM) Strength As A Business
When companies post strong earnings, the stock generally performs well, just like JBT Marel Corporation's ( NYSE:JBTM...
Actualización de narrativa • May 02
JBTM: 2026 Sector Tailwinds And Capital Plans Will Support Upside
Narrative Update: JBT Marel Analysts have lifted JBT Marel's implied upside, with recent price targets rising toward the $190 to $202 range. They point to updated models, modest tweaks to growth and margin assumptions, and supportive 2026 sector trends.Actualización de narrativa • Apr 18
JBTM: 2026 Sector Tailwinds And Capital Plans Are Expected To Support Upside
Analysts have raised JBT Marel's price target to a range of about $190 to $202, up from prior views around $165 to $169. They cite updated models after Q4 results, supportive 2026 sector trends, and evidence of a valuation gap.Actualización de narrativa • Apr 03
JBTM: Higher 2026 Sector Trends And Capital Plans May Support Upside
Analysts have raised their fair value estimate for JBT Marel from $177.50 to $210.00, citing higher price targets from recent Q4 model updates and 2026 sector trend work, which they view as supportive for the stock. Analyst Commentary Recent Street research has turned more constructive on JBT Marel, with higher price targets tied directly to updated models and sector work.Actualización de narrativa • Mar 20
JBTM: 2026 Sector Setup And Food Tech Hub Will Shape Upside Outlook
Analysts have lifted their JBT Marel price target from $160.25 to about $182, citing updated models after recent Q4 results, positive 2026 sector trends, and a reassessment of the valuation gap relative to peers. Analyst Commentary Bullish Takeaways Bullish analysts see the move in price targets toward the US$190 to US$202 range as a reset that better reflects their updated models after Q4, rather than a stretch valuation.Actualización de narrativa • Mar 06
JBTM: Long Dated 2026 Assumptions Will Pressure Future Share Returns
Analysts have lifted their JBT Marel price target range from about $165 to around $202, citing updated models after Q4 results, positive 2026 sector trends, and a reassessment of valuation that now supports a fair value estimate of roughly $121, a lower discount rate of 8.85%, and a higher future P/E assumption of about 18.7, despite more conservative revenue growth and profit margin inputs. Analyst Commentary The latest research updates on JBT Marel center on refreshed models after Q4 results and a reassessment of what investors may be willing to pay for the stock, with reference targets in a range around $190 to $202 and an implied fair value closer to $121.Actualización de narrativa • Feb 19
JBTM: Lower Future P E Multiple Will Weigh On Share Returns
Analysts have maintained their price target for JBT Marel at $105.41, highlighting slightly revised assumptions for the discount rate, revenue growth, profit margin, and future P/E as the main factors supporting this unchanged outlook. What's in the News JBT Marel held an Investor Day event, giving analysts and investors a closer look at the business, capital allocation priorities, and long term financial framework (Key Developments).Actualización de narrativa • Feb 05
JBTM: Projected Margins And P E Reset Will Pressure Share Price
Analysts have maintained their price target for JBT Marel at $105.41. They cite updated assumptions for the discount rate, revenue growth, profit margins and future P/E that keep their valuation view essentially unchanged.Actualización de narrativa • Jan 22
JBTM: Expected 2025 Losses Will Likely Undermine Current Share Price
Analysts have adjusted their price target for JBT Marel to US$105.41, reflecting updated views on discount rates, revenue growth, profit margins, and future P/E assumptions. What's in the News JBT Marel plans an Investor Day event, providing management an opportunity to update investors on the business and capital allocation plans (Key Developments).Actualización de narrativa • Jan 08
JBTM: Investor Day And New Food Solutions Will Shape Balanced Future Outlook
Narrative Update on JBT Marel Analysts have lifted their price target on JBT Marel by US$5 to US$160.25, reflecting updated assumptions for slightly higher revenue growth and a higher future P/E multiple, alongside modest adjustments to the discount rate and profit margin outlook. What's in the News JBT Marel plans to host an Investor Day, giving management a platform to update investors on the business, capital allocation, and medium term priorities (Key Developments).Artículo de análisis • Dec 31
We Think JBT Marel (NYSE:JBTM) Is Taking Some Risk With Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Actualización de narrativa • Dec 23
JBTM: Higher Profit Margins Will Likely Fail To Justify Current Price
Analysts have raised their price target on JBT Marel from approximately 88 dollars to 105 dollars, citing expectations for stronger long term profitability despite moderating revenue growth and a lower projected valuation multiple. What's in the News Raised 2025 revenue guidance to a range of 3,760 million dollars to 3,790 million dollars, signaling confidence in underlying demand despite moderating growth expectations (Corporate Guidance) Updated 2025 GAAP loss per share outlook to a narrower range of 1.05 dollars to 0.75 dollars, highlighting anticipated margin improvements and cost discipline (Corporate Guidance) Launched the Fresh'n Squeeze 1800 Citrus Juicer, a compact countertop system using the company’s industrial grade whole fruit extraction technology to boost juice yield by up to 50 percent per fruit versus traditional cut and press methods (Product Announcement) Positioned the Fresh'n Squeeze 1800 as a labor saving, space efficient solution for grocery retailers, juice bars, hotels, resorts, and coffee shops, enabling menu diversification and new revenue streams from fresh citrus offerings (Product Announcement) Valuation Changes The fair value estimate has risen significantly from approximately 88.23 dollars to 105.41 dollars per share, reflecting higher expected long term profitability.Actualización de narrativa • Dec 09
JBTM: New Food-Processing Offerings Will Drive Margin Expansion And Future Upside
Analysts have modestly raised their price target on JBT Marel, now implying fair value of approximately $155.25 per share. They cite slightly higher long term discount rate assumptions while maintaining robust revenue growth, profit margin, and future valuation expectations.Actualización de narrativa • Nov 25
JBTM: Margin Expansion And New Offerings Will Drive Future Upside
Analysts have raised their price target for JBT Marel to $155.25 from $152.75, citing modest improvements in profit margin projections as the primary driver for this upward adjustment. What's in the News JBT Marel has raised its earnings guidance for the full year 2025, projecting revenue between $3,760 million and $3,790 million and GAAP LPS in the range of $1.05 to $0.75 (Company Guidance).Actualización de narrativa • Nov 07
JBTM: Future Expansion Will Stem From Margin Gains Amid Slower Revenue Growth
Analysts have raised their price target for JBT Marel from $149.42 to $152.75, citing improved profit margin expectations, even as projected revenue growth is expected to moderate. What's in the News JBT Marel raised its earnings guidance for the full year 2025, forecasting revenue between $3,760 million and $3,790 million and GAAP loss per share in the range of $1.05 to $0.75 (Key Developments).Actualización de narrativa • Sep 20
Global Protein Demand And Automation Will Drive Future Expansion
The downward revision of JBT Marel's consensus analyst price target primarily reflects a decline in the anticipated future P/E ratio, with fair value lowered from $162.30 to $149.42. What's in the News JBT Marel is showcasing several innovations at Pack Expo Las Vegas, including the launch of the CIPure Cleaning System, new juicing and pet food technologies, tray sealers, slicers, and a 3D model of a fresh salad line, alongside immersive VR experiences.Actualización de narrativa • Sep 05
Global Protein Demand And Automation Will Drive Future Expansion
The increase in JBT Marel’s consensus analyst price target to $162.30 is primarily driven by a higher forecast valuation multiple (Future P/E), with revenue growth expectations remaining steady. What's in the News JBT Marel re-established full year 2025 earnings guidance, projecting revenue of $3,675 million to $3,725 million, a loss from continuing operations margin of 2.7% to 1.7%, and GAAP loss per share of $1.90 to $1.20.Actualización de narrativa • Aug 07
Global Protein Demand And Automation Will Drive Future Expansion
Despite a notable decline in consensus revenue growth forecasts, JBT Marel's consensus analyst price target has been significantly raised, driven by higher anticipated future P/E multiples, with the fair value increasing from $129.40 to $149.42. What's in the News JBT Marel re-established 2025 revenue guidance of $3,675 million to $3,725 million, with an expected GAAP loss per share of $1.90 to $1.20 and a loss margin of 2.7% to 1.7%, aided by a $70 million to $85 million foreign exchange tailwind.
Nueva narrativa • Feb 09
Merger With Marel Will Improve Operational Efficiency And Create Synergies
Strong revenue growth and margin expansion driven by recovery in key markets and beneficial restructuring efforts could boost future earnings.Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2027 | 4,226 | 351 | 504 | 622 | 7 |
| 12/31/2026 | 4,021 | 232 | 435 | 530 | 8 |
| 6/30/2026 | 3,926 | 193 | 310 | 426 | N/A |
| 3/31/2026 | 3,880 | 168 | 317 | 427 | N/A |
| 12/31/2025 | 3,798 | -50 | 238 | 342 | N/A |
| 9/30/2025 | 3,258 | -110 | 273 | 354 | N/A |
| 6/30/2025 | 2,710 | -139 | 283 | 339 | N/A |
| 3/31/2025 | 2,178 | -111 | 210 | 257 | N/A |
| 12/31/2024 | 1,716 | 85 | 196 | 234 | N/A |
| 9/30/2024 | 1,693 | 144 | 40 | 77 | N/A |
| 6/30/2024 | 1,643 | 137 | -17 | 24 | N/A |
| 3/31/2024 | 1,668 | 135 | -18 | 32 | N/A |
| 12/31/2023 | 1,664 | 129 | -15 | 40 | N/A |
| 9/30/2023 | 1,661 | 109 | 68 | 136 | N/A |
| 6/30/2023 | 1,656 | 104 | 69 | 146 | N/A |
| 3/31/2023 | 1,623 | 101 | 46 | 120 | N/A |
| 12/31/2022 | 1,590 | 104 | 56 | 141 | N/A |
| 9/30/2022 | 1,647 | 103 | 52 | 135 | N/A |
| 6/30/2022 | 1,725 | 107 | 62 | 139 | N/A |
| 3/31/2022 | 1,807 | 111 | 107 | 179 | N/A |
| 12/31/2021 | 1,401 | 93 | 172 | 224 | N/A |
| 9/30/2021 | 1,810 | 117 | 209 | 254 | N/A |
| 6/30/2021 | 1,752 | 105 | 243 | 281 | N/A |
| 3/31/2021 | 1,688 | 107 | 290 | 324 | N/A |
| 12/31/2020 | 1,728 | 109 | 218 | 252 | N/A |
| 9/30/2020 | 1,834 | 121 | 205 | 236 | N/A |
| 6/30/2020 | 1,904 | 137 | 162 | 198 | N/A |
| 3/31/2020 | 1,986 | 139 | N/A | 122 | N/A |
| 12/31/2019 | 1,946 | 129 | N/A | 110 | N/A |
| 9/30/2019 | 1,938 | 130 | N/A | 163 | N/A |
| 6/30/2019 | 1,930 | 123 | N/A | 152 | N/A |
| 3/31/2019 | 1,928 | 123 | N/A | 161 | N/A |
| 12/31/2018 | 1,920 | 104 | N/A | 154 | N/A |
| 9/30/2018 | 1,866 | 81 | N/A | 63 | N/A |
| 6/30/2018 | 1,805 | 81 | N/A | 118 | N/A |
| 3/31/2018 | 1,700 | 66 | N/A | 76 | N/A |
| 12/31/2017 | 1,635 | 82 | N/A | 105 | N/A |
| 9/30/2017 | 1,556 | 86 | N/A | 109 | N/A |
| 6/30/2017 | 1,485 | 80 | N/A | 68 | N/A |
| 3/31/2017 | 1,428 | 80 | N/A | 91 | N/A |
| 12/31/2016 | 1,351 | 68 | N/A | 67 | N/A |
| 9/30/2016 | 1,300 | 66 | N/A | 91 | N/A |
| 6/30/2016 | 1,224 | 58 | N/A | 73 | N/A |
| 3/31/2016 | 1,149 | 53 | N/A | 82 | N/A |
| 12/31/2015 | 1,107 | 56 | N/A | 112 | N/A |
| 9/30/2015 | 1,048 | 50 | N/A | 76 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (41.4% al año) de JBTM es superior a la tasa de ahorro (3.7%).
Beneficios vs. Mercado: Se prevé que los beneficios (41.4% al año) de JBTM crezcan más rápidamente que el mercado US (17.4% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de JBTM crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (4.9% al año) de JBTM crezcan más despacio que el mercado de US (13.6% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 4.9% al año) de JBTM crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de JBTM se prevé que sea elevada dentro de 3 años.
Descubre empresas en crecimiento
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/09/21 05:54 |
| Precio de las acciones al final del día | 2026/09/18 00:00 |
| Beneficios | 2026/06/30 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
JBT Marel Corporation está cubierta por 19 analistas. 8 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Mircea Dobre | Baird |
| Adam Seiden | Barclays |
| "Adam Seiden | Barclays |